SHANGHAI, Aug. 12, 2026 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced that the Investigational New Drug (IND) application for AK0406 injection, the company's first long-acting antiviral drug‑Fc conjugate (AFC) candidate for influenza prophylaxis, has...
Hence then, the article about arkbio announces china ind approval for its antiviral drug fc conjugate afc candidate ak0406 for influenza prophylaxis was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( ArkBio Announces China IND Approval for its Antiviral Drug-Fc Conjugate (AFC) Candidate AK0406 for Influenza Prophylaxis )
Also on site :
- 1956 Rock Hits, Recorded on the Same Day, Began Record 11-Week Run at No. 1 for Elvis 70 Years Ago Today
- 1974 Novel, Written by Best-Selling Author Richard Price, Ranked Among 'Best Coming-of-Age Books' of All Time
- Walmart's Vintage-Inspired Sideboard Has 'Plenty of Storage' and Looks Like a 'Beautiful' Antique